Interleukin-1β Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors

Viviani, Barbara; Gardoni, Fabrizio; Bartesaghi, Stefano; Corsini, Emanuela; Facchi, Alessandra; Galli, Corrado L.; Di Luca, Monica; Marinovich, Marina

doi:10.1074/jbc.m602156200

Cited by 110

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Interleukin-1β Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors

Viviani, Barbara, Gardoni, Fabrizio, Bartesaghi, Stefano, Corsini, Emanuela, Facchi, Alessandra, Galli, Corrado L., Di Luca, Monica, Marinovich, Marina·2006·Journal of Biological Chemistry

DOI 10.1074/jbc.m602156200

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.m602156200

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

IL-1β has complex effects on neurons including disruption of synaptic plasticity, promotion of excitotoxicity, and modulation of α- and γ-secretase activities while reducing β-secretase activity and Aβ levels.
“shows complex and divers effects on neurons including disruption of synaptic plasticity [21], promotion of excitotoxicity [22, 23] and α- and γ-secretase activities, while reducing β-secretase activity [24, 25] and Aβ levels [26, 27].”
From MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer’s disease (2022) · cites this paper as [22]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Interaction with the NMDA receptor locks CaMKII in an active conformation
Bayer, K.-U., De Koninck, P., Leonard, A. S., Hell, J. W., & Schulman, H. (2001) · Nature · doi:10.1038/35081080 · Cited by 732
Molecular determinants of NMDA receptor internalization
Roche, K. W., Standley, S., McCallum, J., Dune Ly, C., Ehlers, M. D., & Wenthold, R. J. (2001) · Nature Neuroscience · doi:10.1038/90498 · Cited by 550
“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506
Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition
Bilbo, S. D., Biedenkapp, J. C., Der-Avakian, A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1748-05.2005 · Cited by 251

Flagged first, then by citations

Research works printed but not linked: 65

Blatteis, 1990, Yale J. Biol. Med., 63, 133
Plata-Salaman, 1991, Neurosci. Biobehav. Rev., 15, 185, 10.1016/S0149-7634(05)80001-6 · DOI
Sei, 1995, Neuroimmunomodulation, 2, 121, 10.1159/000096881 · DOI
Allan, 2001, Nat. Rev. Neurosci., 2, 734, 10.1038/35094583 · DOI
Yamasaki, 1995, Stroke, 26, 676, 10.1161/01.STR.26.4.676 · DOI
Bagetta, 1999, Neuroscience, 89, 1051, 10.1016/S0306-4522(98)00363-7 · DOI
Gallo, 1989, J. Neuroimmunol., 23, 109, 10.1016/0165-5728(89)90029-5 · DOI
Viviani, 2001, Neuroscience, 107, 51, 10.1016/S0306-4522(01)00332-3 · DOI
Vezzani, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 11534, 10.1073/pnas.190206797 · DOI
Schneider, 1998, Proc. Natl. Acad. Sci. U. S. A., 95, 7778, 10.1073/pnas.95.13.7778 · DOI · Paper page
Ross, 2003, J. Neuroimmunol., 144, 61, 10.1016/j.jneuroim.2003.08.030 · DOI
Takahashi, 1996, Am. J. Physiol., 271, R101, 10.1152/ajpcell.1996.271.6.C1887 · DOI
Rachal Pugh, 2001, Neurosci. Biobehav. Rev., 25, 29, 10.1016/S0149-7634(00)00048-8 · DOI
Watkins, 2001, Trends Neurosci., 24, 450, 10.1016/S0166-2236(00)01854-3 · DOI
Viviani, 2003, J. Neurosci., 23, 8692, 10.1523/JNEUROSCI.23-25-08692.2003 · DOI · Paper page
Salter, 2004, Nat. Rev. Neurosci., 5, 317, 10.1038/nrn1368 · DOI
Lynch, 2002, J. Pharmacol. Exp. Ther., 300, 717, 10.1124/jpet.300.3.717 · DOI
Aarts, 2004, Curr. Mol. Med., 4, 137, 10.2174/1566524043479202 · DOI
Kaul, 2001, Nature, 410, 988, 10.1038/35073667 · DOI
Haughey, 2002, J. Acquir. Immune Defic. Syndr., 31, S55, 10.1097/00126334-200210012-00005 · DOI
Ellis, 1997, Arch. Neurol., 54, 416, 10.1001/archneur.1997.00550160054016 · DOI
Brew, 1995, Ann. Neurol., 38, 563, 10.1002/ana.410380404 · DOI
Lipton, 1995, N. Engl. J. Med., 332, 934, 10.1056/NEJM199504063321407 · DOI
Masliah, 1996, Crit. Rev. Neurobiol., 10, 57, 10.1615/CritRevNeurobiol.v10.i1.30 · DOI
Masliah, 1997, Ann. Neurol., 42, 963, 10.1002/ana.410420618 · DOI
Dawson, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 3256, 10.1073/pnas.90.8.3256 · DOI
Toggas, 1994, Nature, 367, 188, 10.1038/367188a0 · DOI
Grynkiewicz, 1985, J. Biol. Chem., 260, 3440, 10.1016/S0021-9258(19)83641-4 · DOI
Gardoni, 2003, J. Biol. Chem., 278, 44745, 10.1074/jbc.M303576200 · DOI
Gardoni, 1998, J. Neurochem., 71, 1733, 10.1046/j.1471-4159.1998.71041733.x · DOI
Denizot, 1986, J. Immunol. Methods, 89, 271, 10.1016/0022-1759(86)90368-6 · DOI · Paper page
Nakazawa, 2001, J. Biol. Chem., 276, 693, 10.1074/jbc.M008085200 · DOI
Takasu, 2002, Science, 295, 491, 10.1126/science.1065983 · DOI
Takagi, 1997, J. Neurochem., 69, 1060, 10.1046/j.1471-4159.1997.69031060.x · DOI
Cheung, 2000, J. Cereb. Blood Flow Metab., 20, 505, 10.1097/00004647-200003000-00009 · DOI
Park, 2002, Bioorg. Med. Chem. Lett, 12, 2711, 10.1016/S0960-894X(02)00523-1 · DOI
Wang, 2004, J. Biol. Chem., 279, 8779, 10.1074/jbc.M309652200 · DOI
Osterhout, 1999, J. Cell Biol., 145, 1209, 10.1083/jcb.145.6.1209 · DOI
Rong, 2001, J. Neurochem., 79, 382, 10.1046/j.1471-4159.2001.00565.x · DOI
Dunah, 2004, Mol. Pharmacol., 65, 121, 10.1124/mol.65.1.121 · DOI
Collingridge, 2004, Nat. Rev. Neurosci., 5, 952, 10.1038/nrn1556 · DOI · Paper page
Prybylowski, 2005, Neuron, 47, 845, 10.1016/j.neuron.2005.08.016 · DOI
Lavezzari, 2003, Neuropharmacology, 45, 729, 10.1016/S0028-3908(03)00308-3 · DOI
Meucci, 1996, J. Neurosci., 16, 4080, 10.1523/JNEUROSCI.16-13-04080.1996 · DOI
Kaul, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 8212, 10.1073/pnas.96.14.8212 · DOI
Giulian, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 2769, 10.1073/pnas.90.7.2769 · DOI
Tyor, 1992, Ann. Neurol., 31, 349, 10.1002/ana.410310402 · DOI
Quan, 1996, Neuroimmunomodulation, 3, 56, 10.1159/000097227 · DOI
Ilyin, 1997, Biochem. Biophys. Res. Commun., 231, 514, 10.1006/bbrc.1997.6131 · DOI
Pugh, 2000, Brain Res., 861, 8, 10.1016/S0006-8993(99)02445-2 · DOI
Milligan, 2001, J. Neurosci., 21, 2808, 10.1523/JNEUROSCI.21-08-02808.2001 · DOI
Barak, 2002, Brain Res., 933, 98, 10.1016/S0006-8993(02)02280-1 · DOI
Lipton, 1997, Immunol. Today, 18, 140, 10.1016/S0167-5699(97)01009-8 · DOI
Barbour, 1989, Nature, 342, 918, 10.1038/342918a0 · DOI
Dreyer, 1995, Eur. J. Neurosci., 7, 2502, 10.1111/j.1460-9568.1995.tb01048.x · DOI
Vesce, 1997, FEBS Lett., 411, 107, 10.1016/S0014-5793(97)00674-1 · DOI
Kalia, 2004, Oncogene, 23, 8007, 10.1038/sj.onc.1208158 · DOI
Vissel, 2001, Nat. Neurosci., 4, 587, 10.1038/88404 · DOI
Kalia, 2003, Neuropharmacology, 45, 720, 10.1016/S0028-3908(03)00313-7 · DOI
Song, 2003, J. Biol. Chem., 278, 33364, 10.1074/jbc.M304240200 · DOI
Besshoh, 2005, J. Neurochem., 93, 186, 10.1111/j.1471-4159.2004.03009.x · DOI
Niimura, 2005, J. Neurochem., 92, 1377, 10.1111/j.1471-4159.2005.02977.x · DOI
Haughey, 2001, J. Neurochem., 78, 457, 10.1046/j.1471-4159.2001.00396.x · DOI
Kutsuwada, 1992, Nature, 358, 36, 10.1038/358036a0 · DOI
Cull-Candy, 2001, Curr. Opin. Neurobiol., 11, 327, 10.1016/S0959-4388(00)00215-4 · DOI · Paper page

Sorted by citations

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
“Listening” and “talking” to neurons: implications of immune activation for pain control and increasing the efficacy of opioids
Watkins, L. R., Hutchinson, M. R., Milligan, E. D., & Maier, S. F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.006 · Cited by 185
Neuroimmune regulation of homeostatic synaptic plasticity
Pribiag, H., & Stellwagen, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.008 · Cited by 106
Association of elevated cytokines with childhood adversity in a sample of healthy adults
Hartwell, K. J., Moran-Santa Maria, M. M., Twal, W. O., Shaftman, S., DeSantis, S. M., McRae-Clark, A. L., & Brady, K. T. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.008 · Cited by 87
MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer’s disease
Pilat, D., Paumier, J.-M., García-González, L., Louis, L., Stephan, D., Manrique, C., Khrestchatisky, M., Di Pasquale, E., Baranger, K., & Rivera, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02407-z · Cited by 28

Authors: Viviani, B., Gardoni, F., Bartesaghi, S., Corsini, E., Facchi, A., Galli, C. L., Di Luca, M., & Marinovich, M.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2006-10
Volume: 281
Issue: 40
Pages: 30212-30222
ISSN: 0021-9258
DOI: 10.1074/jbc.m602156200
Cited by: 110
References: 5
Language: en
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 5115 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Interleukin-1β Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks